(Q45364472)

13 December 2017

Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? (English)

1 reference

13 December 2017

1 reference

1

Susan L Stramer

1 reference

13 December 2017

Shimian Zou

2

1 reference

13 December 2017

Edward P Notari

3

1 reference

13 December 2017

Gregory A Foster

4

1 reference

13 December 2017

David E Krysztof

5

1 reference

13 December 2017

Fatemeh Musavi

6

1 reference

13 December 2017

Roger Y Dodd

7

1 reference

13 December 2017

2 August 2011

1 reference

13 December 2017

1 reference

13 December 2017

52

1 reference

13 December 2017

2

1 reference

13 December 2017

440-446

1 reference

Nucleic acid testing to detect HBV infection in blood donors.

13 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Current incidence and residual risk of hepatitis B infection among blood donors in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Statements from the Taormina expert meeting on occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Hepatitis B virus infection and transfusion medicine: science and the occult

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Sensitivity comparison of two Food and Drug Administration-licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

The consequences of temporary deferral on future whole blood donation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Changing age distribution of the blood donor population in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03283.X

10.1111/J.1537-2995.2011.03283.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference